Withings' updated Body Scan scale tracks 60 different biomarkers

Withings unveiled the second generation Body Scan at CES 2026, a high-tech smart scale offering advanced health monitoring capabilities. This new model builds upon its predecessor, which already featured ECG and body composition analysis. The updated version introduces new features, expanding from 40 to 60 biomarkers, to provide a more comprehensive health assessment. Key additions include Impedance Cardiography (ICG) for heart function monitoring and Bioimpedance Spectroscopy (BIS) to assess cellular health. This data feeds into Withings' AI model, providing insights into hypertension risk and glycemic regulation. The scale offers personalized health trajectory projections and tips to improve "healthspan" through this AI system. The Body Scan 2 has a redesigned display integrated into the retractable handle used for the ECG functionality. Withings aims to secure FDA clearance for a planned launch in the second quarter of 2026. The premium scale will be priced at $599.95, reflecting its advanced features and clinic-in-a-box aspirations. This reflects Withings' commitment to providing at-home health monitoring solutions. The device is designed to combat chronic illnesses influenced by modern lifestyles.